Aptevo Therapeutics Inc.APVONASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-23.79M
↑ 29% vs avg
Percentile
P73
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-33.59M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $-23.79M | -102.8% |
| 2023 | $-11.73M | +44.3% |
| 2022 | $-21.05M | +6.0% |
| 2021 | $-22.39M | +23.9% |
| 2020 | $-29.41M | +30.9% |
| 2019 | $-42.54M | +18.8% |
| 2018 | $-52.40M | -21.9% |
| 2017 | $-42.98M | -9.1% |
| 2016 | $-39.37M | +21.7% |
| 2015 | $-50.29M | - |